Homeobox B13 G84E Mutation and Prostate Cancer Risk.


Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. Electronic address: [Email]


The homeobox B13 (HOXB13) G84E mutation has been recommended for use in genetic counselling for prostate cancer (PCa), but the magnitude of PCa risk conferred by this mutation is uncertain.


Genetic risk,HomeoboxB13,Kin-cohort study,Meta-analysis,Prostate cancer,

OUR Recent Articles